Non-Small-Cell Lung Carcinoma Clinical Trials in Seoul
2 recruitingSeoul, South Korea
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC
Non-Small-Cell Lung Carcinoma
AstraZeneca210 enrolled48 locationsNCT04995523
Recruiting
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
Non-Small-Cell Lung Carcinoma
Novartis Pharmaceuticals250 enrolled12 locationsNCT05703516